Cargando…

PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.

Detalles Bibliográficos
Autores principales: Fujita, M., Itamura, H., miyazaki, M., Ishii, K., Sugihara, A., Sano, H., Okamoto, S., yoshimura, M., Katsuya, H., Ureshino, H., Ando, T., Kimura, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431721/
http://dx.doi.org/10.1097/01.HS9.0000851320.93038.b4
_version_ 1784780133943476224
author Fujita, M.
Itamura, H.
miyazaki, M.
Ishii, K.
Sugihara, A.
Sano, H.
Okamoto, S.
yoshimura, M.
Katsuya, H.
Ureshino, H.
Ando, T.
Kimura, S.
author_facet Fujita, M.
Itamura, H.
miyazaki, M.
Ishii, K.
Sugihara, A.
Sano, H.
Okamoto, S.
yoshimura, M.
Katsuya, H.
Ureshino, H.
Ando, T.
Kimura, S.
author_sort Fujita, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9431721
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94317212022-08-31 PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA. Fujita, M. Itamura, H. miyazaki, M. Ishii, K. Sugihara, A. Sano, H. Okamoto, S. yoshimura, M. Katsuya, H. Ureshino, H. Ando, T. Kimura, S. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431721/ http://dx.doi.org/10.1097/01.HS9.0000851320.93038.b4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Fujita, M.
Itamura, H.
miyazaki, M.
Ishii, K.
Sugihara, A.
Sano, H.
Okamoto, S.
yoshimura, M.
Katsuya, H.
Ureshino, H.
Ando, T.
Kimura, S.
PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
title PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
title_full PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
title_fullStr PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
title_full_unstemmed PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
title_short PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
title_sort pb2122: the efficacy of the standard and intensive chemotherapy in elderly patients with double- and triple-expressor lymphoma.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431721/
http://dx.doi.org/10.1097/01.HS9.0000851320.93038.b4
work_keys_str_mv AT fujitam pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT itamurah pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT miyazakim pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT ishiik pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT sugiharaa pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT sanoh pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT okamotos pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT yoshimuram pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT katsuyah pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT ureshinoh pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT andot pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma
AT kimuras pb2122theefficacyofthestandardandintensivechemotherapyinelderlypatientswithdoubleandtripleexpressorlymphoma